Cheng Zu

The cardiovascular–liver–metabolic syndemic and mortality and life expectancy: two prospective cohort studies

Cardiovascular disease (CVD), metabolic dysfunction–associated steatotic liver disease (MASLD), type 2 diabetes mellitus (T2DM), and obesity frequently coexist and share overlapping pathophysiologic mechanisms, collectively constituting a cardiovascular–liver–metabolic (CLM) synd...